Marcus Co. (NYSE:MCS) – Stock analysts at Barrington Research reduced their Q4 2018 earnings per share estimates for shares of Marcus in a research note issued on Tuesday, April 17th. Barrington Research analyst J. Goss now forecasts that the company will post earnings of $0.28
Melrose Industries Plc made a hostile 7.4-billion-pound ($10.2 billion) bid for GKN Plc, taking its offer directly to shareholders of the U.K. maker of aerospace and automotive components after it spurned an unsolicited approach.
The offer values GKN at 430.1 pence a share in cash and stock, Birmingham, England-based Melrose said in a statement Wednesday. GKN last week rejected an initial....More>>>
Go back a year, and offshore drillers like Noble (NE), Rowan (RDC), Transocean (RIG) and Atwood Oceanics (ATW) had been all but written off–until they weren’t anymore. Since then, investors have been rewarded for picking winners in the group from the losers, as Atwood Oceanics has more than doubled, Transocean has gained 34%, and Rowan has risen 42%, while Noble and Diamond Offshore....More>>>
Bill OReillys top-rated Fox News show may be starting to feel a financial sting after allegations that he sexually harassed several women.
Automakers Hyundai and BMW, financial firm T. Rowe Price, insurer Allstate, drugmaker GlaxoSmithKline and online marketing firm Constant Contact said Tuesday that they have joined Mercedes-Benz....More>>>
2017 was said to be the year of the buyout, and so far, it appears that the M&A prediction is coming true. Last year’s market saw several industries struggling and left some solid companies beaten down. That put them in a vulnerable position as some of their more stable competitors looked for ways to profit from the challenging environment.
Best Biotech ETF: The biotech sector has been greatly outperforming the broader markets over the past three months. In fact, the Nasdaq Biotechnology sector has climbed more than 14% since June, while the Dow is up just 2% in that time.
And we see those biotech gains continuing from here. That’s why we’re bringing readers the best biotech ETF to buy now.
It easily could be a tough day for stocks, as traders are worrying about Spar-a-Lago and moping about yesterdays ugly finish.
Why exactly does the stock market keep wallowing below its March 1 peak?
Analysts have a list of potential culprits: the Donald Trump-Xi Jinping summit that starts today in Florida, fears that tax cuts wont come soon, and the Feds plans to pare back its stockpile....More>>>
A December interest rate hike is on the table and investors have been frantically reallocating their portfolios in anticipation of the announcement. The probability of an interest rate hike at the December 14th FOMC meeting, according to action in the futures market, is currently implied at 95.4%. The image below shows the latest probabilities from CME Group’s Fed Watch Tool
November is typically open enrollment time for millions who gethealth insurance, disability insurance and other benefits from an employer. If youre one of them, among your important choices is whether you want a flexible spending account and how much money to deposit.
FSAs are available through some employers as a part of benefits packages. You can spend FSA money only on qualified medical....More>>>
Pedro Parente, lauded for turning around Brazil’s state-oil giant Petrobras SA, agreed to become chairman of struggling food conglomerate BRF SA, a breakthrough that may end several weeks of fighting among shareholders over who will sit on its board.